Thanks to the development of biological drugs, the treatment of RA has improved drastically in recent years, with the identification of novel treatments, such as Btk, Syk, PI3K and histone deacetylase (HDAC) inhibitors, providing even more hope for patients with RA. The gene discussed is SYK; the disease is rheumatoid arthritis.